February 6, 2019

Vasopressors in Septic Shock

Analysis of UCARDS Survey included in Current Use of Vasopressors in Septic Shock 


We are very pleased to report that the recently-published article Current use of vasopressors in septic shock” Scheeren et al. Ann. Intensive Care (2019) 9:20 included analysis of the results of the ESICM endorsed UCARDS survey (on the Use of CARdiovascular Drugs in Shock), which was circulated to our members in 2016.  839 physicians from 82 countries responded to this survey.

The research was led by Professors Thomas Scheeren & Jean-Louis Teboul, who, through the Society, would like to convey their sincere thanks to all those who took the time to complete this all-important survey. Special mention goes to the members of the ESICM Cardiovascular Dynamics Section for their support.


Results of the research show that the main trigger for vasopressor use was an insufficient mean arterial pressure (MAP) response to initial fluid resuscitation (83%).

The experts agreed on 10 recommendations, 9 of which were based on unanimous or strong (≥ 80%) agreement. They recommended not delaying vasopressor treatment until fluid resuscitation is completed, but rather to start with norepinephrine early, to achieve a target MAP of ≥ 65 mmHg.

Conclusions state that reported vasopressor use in septic shock is compliant with contemporary guidelines. Future studies should focus on individualised treatment targets, including earlier use of vasopressors.


To read the complete article, published in Annals of Intensive Care, go to:


For further information on the CD Section visit


Other completed surveys are found on





1) Scheeren T, et al., Current use of vasopressors in septic shock. Annals of Intensive Care (2019) 9:20

Comment on this news